US EditionPublished • loading... • Updated
Lilly Launches Employer-Connect Platform to Broaden Weight-Loss ...
Eli Lilly's platform connects employers with 15+ administrators, offering uniform pricing and a discounted $449 monthly rate to expand obesity drug coverage.
- On March 5, 2026, Eli Lilly and Company launched the Employer Connect platform to link U.S. employers with independent organizations managing obesity treatment benefits and costs.
- Facing uneven employer coverage, Lilly says roughly half of commercially insured people struggle with access, and many employers hesitate due to high costs; the initiative builds on LillyDirect and telehealth partnerships.
- Lilly priced Zepbound at $449 through the programme, with employers able to subsidize $50 or $100 monthly, and initial partners include GoodRx, Mark Cuban Cost Plus Drug Company and Teladoc Health.
- The programme is designed to expand access and lower out-of-pocket costs, with Lilly's pricing model offering clearer price visibility and some employers adding coverage in the coming months while others delay until 2027.
- Given that obesity affects over 100 million American adults, Medicare will cover these medicines for the first time later this year under landmark deals Lilly and Novo struck with President Donald Trump.
Insights by Ground AI
14 Articles
14 Articles
Coverage Details
Total News Sources14
Leaning Left1Leaning Right0Center9Last UpdatedBias Distribution90% Center
Bias Distribution
- 90% of the sources are Center
90% Center
C 90%
Factuality
To view factuality data please Upgrade to Premium
